Dependencias

Últimas notícias

Ver todas as notícias

ViiV Healthcare anuncia fundo global de £3 milhões

O fundo de £3 milhões disponibilizará recursos financeiros para projetos de investigação que visem estudar o impacto médico e científico que a COVID-19 está a ter nas pessoas que vivem com VIH, e donativos comunitários para ajudar a combater desafios específicos da comunidade VIH criados pela pandemia global.

Partilhar:

Ler mais

Entrevista de João Goulão à VIEW

I left Ireland just as Storm Ciara was hitting Ireland and the UK. All my research on addiction for this issue of VIEW had shown that a visit to Portugal was a must. I was keen to find out how the country had found its way out of a heroin epidemic that had ravaged many of its inhabitants. I also wanted to know what lessons can we learn from its harm reduction policies.

Partilhar:

Ler mais

PANDEMIA

Com uma intervenção em rede e a ajuda, quer das entidades, quer das autarquias, da administração pública da saúde e segurança social e alguns mecenas, estamos a criar condições para suprir as principais necessidades identificadas pelas entidades.

Partilhar:

Ler mais

LAS ADICIONES Y LOS ADICTOS FRENTE AL COVID-19

Y es que surgen muchas preguntas, ¿se incrementará el consumo de sustancias?, ¿habrá un incremento de adictos?, ¿se producirán más recaídas o ¿cómo vamos a seguir atendiendo a las personas que ya están en tratamiento?, entre otras que vamos a intentar responder para situarnos en este nuevo contexto.

Partilhar:

Ler mais

RECOMENDAÇÕES DA DGS SOBRE CORONAVÍRUS/COVID-19

Os Coronavírus são uma família de vírus conhecidos por causar doença no ser humano. A infeção pode ser semelhante a uma gripe comum ou apresentar- se como doença mais grave, como pneumonia.

Partilhar:

Ler mais

Últimos Artigos Científicos

Ver todos os artigos

Informe 2018

La publicación del informe de la Junta Internacional de Fiscalización de Estupefacientes (JIFE) correspondiente a 2018 marca el cincuentenario de la creación de la Junta, de conformidad con la Convención Única de 1961 sobre Estupefacientes1.

Partilhar:

Ler mais

Opioid agonist treatment Guiding principles for legislation and regulations

Foreword In the United States, 12 prosecutors have been tasked with identifying doctors and pharmacists throughout the country who prescribe or dispense medicines containing opioids without any regard as to how they are to be used. At the same time, the uncontrolled use of opioids has caused a new spate of fatalities in North America, which is in the throes of a real public health crisis. Why is the United States undergoing such a crisis? What can Europe do to avoid it?

Partilhar:

Ler mais

The positive effect on ketamine as a priming adjuvant in antidepressant treatment

INTRODUCTION Major depression (MD) is a highly incident and prevalent multifactorial disease responsible for great personal and socioeconomic burden.1 Currently used therapeutic regimens have important limitations such as long-time lag for clinical response, induction of resistance or even response failure.

Partilhar:

Ler mais

Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice

Elimination of HIV-1 requires clearance and removal of integrated proviral DNA from infected cells and tissues. Here, sequential long-acting slow-effective release antiviral therapy (LASER ART) and CRISPR-Cas9 demonstrate viral clearance in latent infectious reservoirs in HIV-1 infected humanized mice. HIV-1 subgenomic DNA

Partilhar:

Ler mais

Developments in the European cannabis market

This paper provides an overview of established and emerging cannabis products in Europe. For each type of product, major issues in its production, distribution, use and effects on health are detailed. In doing so, the paper seeks to inform a discussion of the new challenges that may emerge in the monitoring of these products and the consequences of their use.

Partilhar:

Ler mais